Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 11, 2011
In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues
Caroline Haglund, Anna Aleskog, Peter Nygren, et al.
Biochemical Pharmacology
|
August 13, 2013
The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo
Sara Strese, Malin Wickström, Peder Fredlund Fuchs, et al.
International Journal of Oncology
|
January 25, 2021
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines
Stefan Holzhauser, Monika Lukoseviciute, Christina Papachristofi, et al.
BMC Cancer
|
August 20, 2014
The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling
Yumei Diao, Mohammed Ferdous-Ur Rahman, Victoria E Villegas, et al.
Cancers
|
January 1, 2020
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
Cecilia Dyberg, Teodora Andonova, Thale Kristin Olsen, et al.
BMC Cancer
|
April 3, 2016
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
Cecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, et al.
Molecular & Cellular Proteomics : MCP
|
October 30, 2009
High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation
Karl-Johan Leuchowius, Malin Jarvius, Malin Wickström, et al.
International Journal of Cancer
|
December 6, 2008
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
Ebba Palmberg, John Inge Johnsen, Janna Paulsson, et al.
International Journal of Oncology
|
October 23, 2019
Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines
Ourania N Kostopoulou, Stefan Holzhauser, Birthe K A Lange, et al.
Cancers
|
February 13, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro
Conny Tümmler, Gianina Dumitriu, Malin Wickström, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Cancer Chemotherapy and Pharmacology
|
October 11, 2011
In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues
Caroline Haglund, Anna Aleskog, Peter Nygren, et al.
Biochemical Pharmacology
|
August 13, 2013
The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo
Sara Strese, Malin Wickström, Peder Fredlund Fuchs, et al.
International Journal of Oncology
|
January 25, 2021
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines
Stefan Holzhauser, Monika Lukoseviciute, Christina Papachristofi, et al.
BMC Cancer
|
August 20, 2014
The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling
Yumei Diao, Mohammed Ferdous-Ur Rahman, Victoria E Villegas, et al.
Cancers
|
January 1, 2020
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
Cecilia Dyberg, Teodora Andonova, Thale Kristin Olsen, et al.
BMC Cancer
|
April 3, 2016
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
Cecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, et al.
Molecular & Cellular Proteomics : MCP
|
October 30, 2009
High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation
Karl-Johan Leuchowius, Malin Jarvius, Malin Wickström, et al.
International Journal of Cancer
|
December 6, 2008
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
Ebba Palmberg, John Inge Johnsen, Janna Paulsson, et al.
International Journal of Oncology
|
October 23, 2019
Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines
Ourania N Kostopoulou, Stefan Holzhauser, Birthe K A Lange, et al.
Cancers
|
February 13, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro
Conny Tümmler, Gianina Dumitriu, Malin Wickström, et al.
Page
of 6